Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia-Reference-Cited by-同舟云学术

Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia

Published:2017-08-07 Issue:4 Volume:59 Page:837-843
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dhere Vishal¹,Edelman Scott¹,Waller Edmund K.²,Langston Amelia²,Graiser Michael²,Connolly Erin C.¹,Switchenko Jeffrey M.³,Esiashvili Natia¹,Khan Mohammad K.¹

Affiliation:

1. Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA;

2. Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA, USA;

3. Department of Biostatistics and Bioinformatics, Winship Cancer Institute at Emory University, Atlanta, GA, USA

Funder

Biostatistics and Bioinformatics Shared Resource of Winship Cancer Institute of Emory University

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1361027

Reference12 articles.

1. Busulfan in hematopoietic stem cell transplant setting

2. Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

3. Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)

4. Mini-allografts: ongoing trials in humans

5. Comparison of Reduced-Intensity and Myeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: A Meta-Analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors;Journal of Thrombosis and Haemostasis;2024-08

2. Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era;Blood Advances;2021-12-20

3. Therapeutic Drug Monitoring of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Single-Center Study in Taiwan;Pharmaceuticals;2021-06-26

4. Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology;European Journal of Clinical Pharmacology;2020-11-11

5. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report;Blood Advances;2020-07-14